Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to $38.5 million.

  • Integra Lifesciences Holdings' Depreciation & Amortization (CF) rose 712.16% to $38.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $151.0 million, marking a year-over-year increase of 1243.74%. This contributed to the annual value of $140.9 million for FY2024, which is 1407.23% up from last year.
  • Latest data reveals that Integra Lifesciences Holdings reported Depreciation & Amortization (CF) of $38.5 million as of Q3 2025, which was up 712.16% from $37.7 million recorded in Q2 2025.
  • Integra Lifesciences Holdings' 5-year Depreciation & Amortization (CF) high stood at $38.5 million for Q3 2025, and its period low was $29.2 million during Q1 2021.
  • For the 5-year period, Integra Lifesciences Holdings' Depreciation & Amortization (CF) averaged around $32.4 million, with its median value being $30.7 million (2021).
  • As far as peak fluctuations go, Integra Lifesciences Holdings' Depreciation & Amortization (CF) crashed by 406.56% in 2022, and later surged by 2166.46% in 2025.
  • Quarter analysis of 5 years shows Integra Lifesciences Holdings' Depreciation & Amortization (CF) stood at $30.7 million in 2021, then decreased by 4.07% to $29.5 million in 2022, then increased by 5.05% to $31.0 million in 2023, then increased by 21.31% to $37.6 million in 2024, then increased by 2.48% to $38.5 million in 2025.
  • Its Depreciation & Amortization (CF) was $38.5 million in Q3 2025, compared to $37.7 million in Q2 2025 and $37.2 million in Q1 2025.